Back to Trials
NCT07561827PHASE3Recruiting

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

University of California, San Francisco

Start Date

6/6/2025

Completion Date

1/26/2027

Summary

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Eligibility Criteria

Age Range: 10 years to 18 years

Inclusion Criteria: * Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis * Undergoing Posterior Spinal Fusion (PSF) Surgery Exclusion Criteria: * Patients with forms of scoliosis other than AIS or NM Scoliosis. * Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery * Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids

Interventions

DRUG

Ropivacaine Hydrocloride

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Adolescent Idiopathic Scoliosis (AIS)Neuromuscular ScoliosisAdolescent Idiopathic Scoliosis

Locations

University of California San Francisco

San Francisco, California 94158

United States